Creatine phosphokinase (CPK) is an enzyme found primarily in muscle cells. It plays a vital role in energy production within the body by catalyzing the conversion of creatine to phosphocreatine. CPK levels in the blood can serve as a marker for muscle damage or injury, as elevated levels may indicate muscle breakdown. It is commonly used in clinical settings to diagnose conditions such as myocardial infarction (heart attack), muscular dystrophy, and rhabdomyolysis. The procedure to test CPK involves drawing a blood sample from the patient. The blood is then analyzed in a laboratory to measure the level of creatine phosphokinase (CPK) present. This is already existing invasive concept to detect pain type. Our current focus is on creating a non- invasive method to determine the root cause of pain. By leveraging wearable devices and AI, we strive to offer users a practical and accessible solution for assessing pain intensity and comprehending the nature of their discomfort.